Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV) Meeting Abstract
| Authors: | Hudis, C.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V. G.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; Bell-McGuinn, K. M.; Chera, H.; Zaugg, B.; Ro, S. K.; Li, S.; Schwartzberg, L. S. |
| Abstract Title: | Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880300148 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2011.29.15_suppl.1009 |
| Notes: | Meeting Abstract: 1009 -- Source: Wos |
